TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza
Vaccines developer receives Chinese government funding for pandemic flu vaccine R&D
January 17th, 2006
Sinovac Biotech Ltd. (SVA) announced it has received RMB7,000,000 (US$867,000) from the Chinese Ministry of Science and Technology for the preclinical trials research and development (R&D) of its proprietary pandemic flu vaccine (Panflu) for humans. Since April 2004, Sinovac has received over US$1,000,000 from different departments of Chinese government for its pandemic flu vaccine R&D. This government funding to Sinovac, more than any other vaccine project for its study in preclinical stage to date, is expected to continue. This work has a high priority because of a possible flu pandemic. Most health officials estimate a flu pandemic would last a...
Source: TB & Outbreaks Week (2006-01-17)
|
